MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib
Matthias Wirth(Humboldt-Universität zu Berlin), Günter Schneider(Klinikum rechts der Isar)
Cited by 64
Related Papers
IKKα controls p52/RelB at the skp2 gene promoter to regulate G1‐ to S‐phase progression
|The EMBO Journal|2006|91
HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells
|Molecular Cancer|2010|80
Casein kinase II inhibition induces apoptosis in pancreatic cancer cells
|Oncology Reports|2007|40
Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC
|Molecular Oncology|2020|23
AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer
|Cellular and Molecular Life Sciences|2022|17